Tristel - Asset Resilience Ratio

Latest as of December 2025: 13.71%

Tristel (TSTL) has an Asset Resilience Ratio of 13.71% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check TSTL capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

GBX6.23 Million

≈ $758.01 USD Cash + Short-term Investments

Total Assets

GBX45.43 Million

≈ $5.53K USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Tristel's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Tristel to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tristel's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Tristel worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX6.23 Million	13.71%
Total Liquid Assets	GBX6.23 Million	13.71%

Asset Resilience Insights

Moderate Liquidity: Tristel has 13.71% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Tristel Industry Peers by Asset Resilience Ratio

Compare Tristel's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pegavision TW:6491	Medical Instruments & Supplies	17.14%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%
Nyxoah BR:NYXH	Medical Instruments & Supplies	12.40%
Ocumetics Technology Corp V:OTC	Medical Instruments & Supplies	0.00%

Annual Asset Resilience Ratio for Tristel (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Tristel.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	9.26%	GBX4.20 Million ≈ $511.02	GBX45.33 Million ≈ $5.52K	-3.54pp
2024-06-30	12.81%	GBX5.65 Million ≈ $687.44	GBX44.11 Million ≈ $5.37K	+6.93pp
2023-06-30	5.88%	GBX2.43 Million ≈ $295.90	GBX41.37 Million ≈ $5.03K	-25.02pp
2019-06-30	30.90%	GBX8.80 Million ≈ $1.07K	GBX28.49 Million ≈ $3.47K	+33.08pp
2018-06-30	-2.18%	GBX-492.00K ≈ $-59.86	GBX22.54 Million ≈ $2.74K	--

pp = percentage points

About Tristel

LSE:TSTL UK Medical Instruments & Supplies

Market Cap

$2.26 Million

GBX18.60 Billion GBX

Market Cap Rank

#29838 Global

#662 in UK

Share Price

GBX387.50

Change (1 day)

+0.00%

52-Week Range

GBX352.00 - GBX440.00

All Time High

GBX617.87